Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × pamiparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 6 Glioblastoma 4 Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Tumor 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Temozolomide 140 Bevacizumab 63 Radiotherapy 54 Magnetic Resonance Spectroscopy 52 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 16 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749187 2026-03-13

PNOC017

University of California, San Francisco

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡